About INVO Bioscience (OTCMKTS:IVOB)
INVO Bioscience, Inc., a medical device company, provides novel solutions in assisted reproductive technologies to the reproductive health care community in the United States, Canada, South and Central America, Latin America, India, the Middle East, and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVO procedure, an alternative infertility treatment that enables the conception and embryo development inside the woman's body. The company sells its products through established and new distributors, IVF centers, and physicians, as well as directly to the physicians. INVO Bioscience, Inc. is based in Medford, Massachusetts.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / Sales349.20
Price / CashN/A
Book Value($0.04) per share
Price / Book-17.00
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on Assets-144.58%
INVO Bioscience (OTCMKTS:IVOB) Frequently Asked Questions
What is INVO Bioscience's stock symbol?
INVO Bioscience trades on the OTCMKTS under the ticker symbol "IVOB."
How were INVO Bioscience's earnings last quarter?
INVO Bioscience (OTCMKTS:IVOB) announced its earnings results on Monday, May, 15th. The company reported $0.00 EPS for the quarter. The firm earned $0.05 million during the quarter. View INVO Bioscience's Earnings History.
When is INVO Bioscience's next earnings date?
Who are some of INVO Bioscience's key competitors?
Some companies that are related to INVO Bioscience include Antares Pharma (ATRS), RenovaCare (RCAR), Endologix (ELGX), Westaim (WEDXF), GenMark Diagnostics (GNMK), Tandem Diabetes Care (TNDM), Pulse Biosciences (PLSE), T2 Biosystems (TTOO), Orthopediatrics (KIDS), Cytosorbents (CTSO), Nuvectra (NVTR), IRadimed (IRMD), SeaSpine (SPNE), Restoration Robotics (HAIR) and Alphatec (ATEC).
Who are INVO Bioscience's key executives?
INVO Bioscience's management team includes the folowing people:
- Ms. Kathleen T. Karloff, Co-Founder, Chairman, Chief Exec. Officer and Pres (Age 63)
- Mr. Robert Joseph Bowdring Jr., Acting Chief Financial Officer, Treasurer, Sec., Consultant and Director (Age 60)
Has INVO Bioscience been receiving favorable news coverage?
Media stories about IVOB stock have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. INVO Bioscience earned a coverage optimism score of 0.04 on Accern's scale. They also assigned news coverage about the company an impact score of 47.23 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
How do I buy shares of INVO Bioscience?
Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is INVO Bioscience's stock price today?
One share of IVOB stock can currently be purchased for approximately $0.68.
How big of a company is INVO Bioscience?
INVO Bioscience has a market capitalization of $99.56 million and generates $280,000.00 in revenue each year. INVO Bioscience employs 1 workers across the globe.
How can I contact INVO Bioscience?
INVO Bioscience's mailing address is 407R MYSTIC AVENUE SUITE 34C, MEDFORD MA, 02155. The company can be reached via phone at 978-878-9505 or via email at [email protected]
MarketBeat Community Rating for INVO Bioscience (IVOB)MarketBeat's community ratings are surveys of what our community members think about INVO Bioscience and other stocks. Vote "Outperform" if you believe IVOB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVOB will underperform the S&P 500 over the long term. You may vote once every thirty days.
INVO Bioscience (OTCMKTS:IVOB) Analyst Ratings History
(Data available from 4/26/2016 forward)
INVO Bioscience (OTCMKTS:IVOB) Earnings History and Estimates Chart
INVO Bioscience (OTCMKTS IVOB) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/21/2018|| || || || || || || || |
|5/15/2017||Q1 2017||($0.0010)||$0.05 million||View||N/A|
INVO Bioscience (OTCMKTS:IVOB) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
INVO Bioscience (OTCMKTS IVOB) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 0.04%
INVO Bioscience (OTCMKTS IVOB) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/5/2018||Claude Ranoux||Major Shareholder||Sell||13,642||$0.18||$2,455.56|| |
|2/23/2018||Claude Ranoux||Major Shareholder||Sell||100||$0.18||$18.00|| |
|2/21/2018||Claude Ranoux||Major Shareholder||Sell||122,322||$0.11||$13,455.42|| |
|2/16/2018||Claude Ranoux||Major Shareholder||Sell||13,890||$0.11||$1,527.90|| |
|2/13/2018||Claude Ranoux||Major Shareholder||Sell||12,808||$0.11||$1,408.88|| |
|2/7/2018||Claude Ranoux||Major Shareholder||Sell||16,115||$0.11||$1,772.65|| |
|2/2/2018||Claude Ranoux||Major Shareholder||Sell||18,700||$0.12||$2,244.00|| |
|1/29/2018||Claude Ranoux||Major Shareholder||Sell||31,319||$0.12||$3,758.28|| |
|1/25/2018||Claude Ranoux||Major Shareholder||Sell||2,100||$0.12||$252.00|| |
|1/22/2018||Claude Ranoux||Major Shareholder||Sell||46,500||$0.12||$5,580.00|| |
|1/16/2018||Claude Ranoux||Major Shareholder||Sell||600||$0.15||$90.00|| |
|1/12/2018||Claude Ranoux||Major Shareholder||Sell||12,545||$0.15||$1,881.75|| |
|1/8/2018||Claude Ranoux||Major Shareholder||Sell||100,000||$0.13||$13,000.00|| |
|1/4/2018||Claude Ranoux||Major Shareholder||Sell||2,834||$0.15||$425.10|| |
|12/29/2017||Claude Ranoux||Major Shareholder||Sell||4,525||$0.16||$724.00|| |
|12/27/2017||Claude Ranoux||Major Shareholder||Sell||10,000||$0.17||$1,700.00|| |
|12/20/2017||Claude Ranoux||Major Shareholder||Sell||10,000||$0.17||$1,700.00|| |
|12/18/2017||Claude Ranoux||Major Shareholder||Sell||30,000||$0.17||$5,100.00|| |
|12/11/2017||Claude Ranoux||Major Shareholder||Sell||50,000||$0.18||$9,000.00|| |
INVO Bioscience (OTCMKTS IVOB) News Headlines
|The Fertility Institute of New Orleans Expands Reproductive Services with INVOcell|
finance.yahoo.com - April 24 at 9:44 AM
|America Institute of Reproductive Medicine - Alabama Adds INVOcell to its Scope of Services|
finance.yahoo.com - April 10 at 10:12 AM
|Fertility Institute of Hawaii becomes First Fertility Clinic in Hawaii to Adopt INVOcell|
finance.yahoo.com - April 3 at 10:08 AM
|INVO Bioscience Reports Year End 2017 Financial Results|
finance.yahoo.com - March 29 at 10:13 AM
|Palm Beach Fertility Center Expands its Scope of Reproductive Services with INVOCell as INVO Bioscience Enters Florida|
finance.yahoo.com - March 20 at 9:59 AM
|INVO Bioscience Expands its Training Capacity|
finance.yahoo.com - March 13 at 10:14 AM
|INVOcell Fertility Treatment Now Offered at Family Beginnings in Indianapolis|
finance.yahoo.com - March 6 at 9:40 AM
|INVO Bioscience Progresses in Developing Market for INVOcell in Hong Kong and Macao|
finance.yahoo.com - February 28 at 9:41 AM
|Claude Ranoux Sells 122,322 Shares of Invo Bioscience Inc (IVOB) Stock|
www.americanbankingnews.com - February 22 at 7:26 PM
|Alabama Fertility Breaking New Ground to be the First to Offer INVOcell in Alabama|
finance.yahoo.com - February 20 at 9:19 AM
|Carolina Conceptions Expands its Menu of Reproductive Services with INVOcell|
finance.yahoo.com - February 8 at 9:07 AM
|Invo Bioscience Inc (IVOB) Major Shareholder Claude Ranoux Sells 100,000 Shares|
www.americanbankingnews.com - January 9 at 7:56 PM
|INVO Bioscience Reports Third Quarter 2017 Financial Results|
finance.yahoo.com - November 15 at 3:24 AM
|INVO Bioscience Appoints Michael J. Campbell and Steven Shum to Its Board of Directors|
finance.yahoo.com - October 11 at 4:48 PM
|First INVO Babies Born in California|
finance.yahoo.com - September 25 at 9:23 AM
|Dr. Francisco Arredondo Opens First U.S. INVOcell Center in McAllen, Texas|
finance.yahoo.com - September 6 at 7:59 PM
|INVO Bioscience Reports Record Second Quarter 2017 Financial Results|
finance.yahoo.com - August 11 at 4:37 AM
|INVOcell Fertility Treatment Now Offered at the Center for Reproductive Health at Tri-Star Centennial Medical Center in Nashville|
finance.yahoo.com - August 3 at 8:14 PM
|Piedmont Reproductive Endocrinology Group in South Carolina Successfully Launches INVOcell|
finance.yahoo.com - August 2 at 1:34 AM
|Houston Fertility Center to Begin Offering INVOcell Procedure to Patients in Southeast Texas|
finance.yahoo.com - July 19 at 10:40 PM
|The Atlantic Magazine Publishes Article on Breakthrough IVF Treatment by INVO Bioscience|
finance.yahoo.com - July 14 at 4:44 AM
|INVO BIOSCIENCE, INC. Files SEC form 10-K, Annual Report|
biz.yahoo.com - March 17 at 6:14 PM
|INVO BIOSCIENCE, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Amendments to Articles of In|
biz.yahoo.com - January 6 at 6:39 PM
|INVO BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers|
biz.yahoo.com - September 26 at 5:47 PM
|INVO BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits|
biz.yahoo.com - November 3 at 11:59 AM
INVO Bioscience (OTCMKTS:IVOB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
INVO Bioscience (OTCMKTS IVOB) Stock Chart for Thursday, April, 26, 2018